28486810|t|A Facile Strategy to Prepare an Enzyme - Responsive Mussel Mimetic Coating for Drug Delivery Based on Mesoporous Silica Nanoparticles
28486810|a|Surface functional mesoporous silica nanoparticles (MSNs) have been widely used as promosing materials for drug delivery. Herein, we reported a facile strategy to construct MSNs coated by enzyme - resposive polylysine - dopamine (PLDA) films through self-polymerization of dopamine derivative lysine - dopamine, in which the drug could be loaded and delivered efficiently. In detail, RhB or DOX was used as a drug model and loaded in functional MSNs via a one-pot procedure among MSNs, drug, and lysine - dopamine (LDA) under basic conditions. Owing to the fact that the peptide bonds between lysine and dopamine can be cleaved under triggering by pepsin, the resulting RhB / DOX @ PLDA - MSNs exibit enzyme - responsive characterization. After the DOX @ PLDA - MSNs enter into the cancer cells, the drug can be released effectively through degradation of peptide bonds under the influence of enzyme in cancer cells, which shows marked anticancer activity in vitro. This facile strategy may provide a new platform to construct enzyme - responsive controlled drug delivery systems.
28486810	9	17	Strategy	T062	UMLS:C0035171
28486810	32	38	Enzyme	T103	UMLS:C0014442
28486810	52	58	Mussel	T204	UMLS:C0026871
28486810	79	92	Drug Delivery	T058	UMLS:C1881966
28486810	102	119	Mesoporous Silica	T103	UMLS:C0037098
28486810	134	141	Surface	T082	UMLS:C0205148
28486810	153	170	mesoporous silica	T103	UMLS:C0037098
28486810	186	190	MSNs	T103	UMLS:C0037098
28486810	227	236	materials	T103	UMLS:C0005479
28486810	241	254	drug delivery	T058	UMLS:C1881966
28486810	285	293	strategy	T062	UMLS:C0035171
28486810	307	311	MSNs	T103	UMLS:C0037098
28486810	322	328	enzyme	T103	UMLS:C0014442
28486810	341	351	polylysine	T103	UMLS:C0032518
28486810	354	362	dopamine	T103	UMLS:C0013030
28486810	364	368	PLDA	T103	UMLS:C0013030
28486810	407	415	dopamine	T103	UMLS:C0013030
28486810	427	433	lysine	T103	UMLS:C0024337
28486810	436	444	dopamine	T103	UMLS:C0013030
28486810	459	463	drug	T103	UMLS:C0013227
28486810	518	521	RhB	T103	UMLS:C0073194
28486810	525	528	DOX	T103	UMLS:C0013089
28486810	543	547	drug	T103	UMLS:C1254351
28486810	548	553	model	T062	UMLS:C1515654
28486810	579	583	MSNs	T103	UMLS:C0037098
28486810	614	618	MSNs	T103	UMLS:C0037098
28486810	620	624	drug	T103	UMLS:C1254351
28486810	630	636	lysine	T103	UMLS:C0024337
28486810	639	647	dopamine	T103	UMLS:C0013030
28486810	649	652	LDA	T103	UMLS:C0013030
28486810	660	665	basic	T103	UMLS:C0178499
28486810	727	733	lysine	T103	UMLS:C0024337
28486810	738	746	dopamine	T103	UMLS:C0013030
28486810	782	788	pepsin	T103	UMLS:C0030909
28486810	804	807	RhB	T103	UMLS:C0073194
28486810	810	813	DOX	T103	UMLS:C0013089
28486810	816	820	PLDA	T103	UMLS:C0013030
28486810	823	827	MSNs	T103	UMLS:C0037098
28486810	835	841	enzyme	T103	UMLS:C0014442
28486810	883	886	DOX	T103	UMLS:C0013089
28486810	889	893	PLDA	T103	UMLS:C0013030
28486810	896	900	MSNs	T103	UMLS:C0037098
28486810	916	928	cancer cells	T017	UMLS:C0334227
28486810	934	938	drug	T103	UMLS:C1254351
28486810	975	1003	degradation of peptide bonds	T038	UMLS:C0597304
28486810	1027	1033	enzyme	T103	UMLS:C0014442
28486810	1037	1049	cancer cells	T017	UMLS:C0334227
28486810	1070	1080	anticancer	T103	UMLS:C0003392
28486810	1112	1120	strategy	T062	UMLS:C0035171
28486810	1161	1167	enzyme	T103	UMLS:C0014442
28486810	1192	1213	drug delivery systems	T058	UMLS:C1881966